zeaxanthin

DIETARY_SUPPLEMENT4 trials

Sponsors

Maastricht University Medical Center, Paul S. Bernstein, University of Georgia, Valley Health System

Conditions

Age-related Macular DegenerationBehavior and Behavior MechanismsCancer MetastaticIdiopathic Juxtafoveal TelangiectasiaMetastatic Solid Tumor

Phase 1

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

RecruitingNCT05232409

Valley Health SystemCancer Metastatic, Metastatic Solid Tumor

Start: 2022-04-17End: 2026-03-31Target: 72Updated: 2023-04-20

Unknown Phase

The Effect of Eggs and Egg Products on Macular Pigment

CompletedNCT00527553

Maastricht University Medical CenterAge-related Macular Degeneration

Start: 2007-10-31End: 2008-02-29Updated: 2018-04-26

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

CompletedNCT01354093

Paul S. BernsteinIdiopathic Juxtafoveal Telangiectasia

Start: 2011-11-30End: 2017-01-31Updated: 2017-06-23

The Effects of a Zeaxanthin Intervention on Visuomotor Function

CompletedNCT02017418

University of GeorgiaBehavior and Behavior Mechanisms

Start: 2012-02-29End: 2014-07-31Updated: 2015-05-27

Related Papers

The Effect of Modified Eggs and an Egg-Yolk Based Beverage on Serum Lutein and Zeaxanthin Concentrations and Macular Pigment Optical Density: Results from a Randomized Trial

PLoS ONE2014-03-2749 citations